![](/img/cover-not-exists.png)
PDB70 - ECONOMIC EVALUATION OF THE USE OF RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR (HEBERPROT-P®) AS AN ADJUVANT OF CONVENTIONAL THERAPY FOR THE TREATMENT OF DIABETIC FOOT ULCER
Muzio, V., Gonzalez, O., Garcia, D., Flores, B., Alcantara, J.L., Figueroa, A., Lemus, F.Volume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.775
Date:
October, 2018
File:
PDF, 378 KB
english, 2018